Home › Brain Tumors › NCT05480644
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
RecruitingObservational study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Have a confirmed diagnosis of primary or metastatic brain tumor (histology or imaging as appropriate) Exclusion Criteria: * None
About the study
The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.
Sponsor: Duke University · Participants: 300 · Started: Dec 1, 2022
Contact the study team
- Kaitlin Bailey, RN OCN · Phone: (919) 668-3726
Official record on ClinicalTrials.gov — NCT05480644
Locations in the U.S.
| North Carolina | Duke Cancer Center, Durham |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.